We examined the effects of an angiotensin-converting enzyme inhibit'/> Captopril improves cerebrovascular structure and function in old hypertensive rats
首页> 美国卫生研究院文献>British Journal of Pharmacology and Chemotherapy >Captopril improves cerebrovascular structure and function in old hypertensive rats
【2h】

Captopril improves cerebrovascular structure and function in old hypertensive rats

机译:卡托普利改善老年高血压大鼠的脑血管结构和功能

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

class="enumerated" style="list-style-type:decimal">We examined the effects of an angiotensin-converting enzyme inhibitor (ACEI), captopril, on cerebral arterioles in young and old spontaneously hypertensive rats (SHR).Animals were anesthetized with sodium pentobarbitone (60 mg kg−1 day−1). We measured cerebral blood flow (CBF, arbitrary units) and cerebral arteriolar internal diameter (ID, μm) prior to and during stepwise hypotension (SH) in 6- (WKY-6) and 15-month-old (WKY-15) Wistar Kyoto rats and in age-matched SHR that were untreated (SHR-6 and SHR-15) or treated for 3 months with captopril (SHR-6C, 105±2 mg kg−1 day−1 and SHR-15C, 94±1 mg kg−1 day−1). ID and cross-sectional area of the vessel wall (CSA) were measured in deactivated (EDTA) cerebral arterioles during a second SH.Captopril decreased the lower limit of CBF autoregulation (61±6 in SHR-6C and 51±2 in SHR-15C versus 52±6 in WKY-6 and 62±7 in WKY-15 and 83±14 mmHg in SHR-6 and 120±19 mmHg in SHR-15; P<0.05) and CSA (510±21 in SHR-6C and 585±25 in SHR-15C versus 529±12 in WKY-6 and 549±20 in WKY-15 and 644±38 mmHg in SHR-6 and 704±38 mmHg in SHR-15; P<0.05).Captopril increased cerebral arteriolar external diameter of SHR (105±5 in SHR-6C and 94±4 in SHR-15C vs 125±8 in WKY-6 and 108±3 in WKY-15 and 83±2 mmHg in SHR-6 and 80±2 mmHg in SHR-15 for a pial arteriolar pressure step of 35–39 mmHg; P<0.05). Captopril attenuated increases in cerebral arteriolar distensibility in young SHR.Thus, ACEIs attenuate eutrophic and hypertrophic inward remodeling of cerebral arterioles in young and old SHR, thus decreasing the lower limit of CBF autoregulation.
机译:class =“ enumerated” style =“ list-style-type:decimal”> <!-list-behavior =枚举前缀-word = mark-type = decimal max-label-size = 0-> 我们研究了血管紧张素转换酶抑制剂(ACEI)卡托普利对年轻和老龄自发性高血压大鼠(SHR)脑小动脉的影响。 用戊巴比妥钠(60μmgkg -1 day -1 )。我们在6-(WKY-6)和15个月大(WKY-15)Wistar中在逐步降低血压(SH)之前和期间测量了脑血流量(CBF,任意单位)和脑小动脉内径(ID,μm)未经处理(SHR-6和SHR-15)或用卡托普利治疗3个月(SHR-6C,105±2 mg kg -1 day )的京都大鼠和年龄匹配的SHR -1 和SHR-15C,94±1 mg kg -1 day -1 )。在第二次SH期间在失活的(EDTA)脑小动脉中测量了血管壁的ID和血管壁的横截面积。 卡托普利降低了CBF自动调节的下限(SHR-6C中为61±6)在SHR-15C中为51±2,而在WKY-6中为52±6,在WKY-15中为62±7,在SHR-6中为83±14 mmHg,在SHR-15中为120±19 mmHg; P <0.05)和CSA( SHR-6C为510±21,SHR-15C为585±25,WKY-6为529±12,WKY-15为549±20,SHR-6为644±38 mmHg,SHR-15为704±38 mmHg; P <0.05)。 卡托普利增加了SHR的脑小动脉外径(SHR-6C为105±5,SHR-15C为94±4,而WKY-6为125±8,WKY为108±3对于SHR-6中的-15和83±2 mmHg,以及在SHR-15中的80±2 mmHg(当心室小动脉压力阶跃为35–39 mmHg时,P <0.05)。卡托普利减弱了年轻SHR中脑小动脉可扩张性的增加。 因此,ACEI减弱了年轻和老SHR中脑小动脉的富营养和肥大性向内重塑,从而降低了CBF自动调节的下限。 < / ol>

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号